BRIEF-Eleven Biotherapeutics completes exclusive licensing deal By: Reuters: Company News August 16, 2016 at 07:39 AM EDT * Completes exclusive licensing deal for IL-6 antagonist antibody technology, including EBI-031 Read More >>